With epigenetic reprogramming to reverse age-related cognitive decline in mammals
epigenetic reprogramming
cognitive decline
neural plasticity
aging reversal
DNA methylation
Investigating inflammasome inhibition as a therapeutic strategy for age-related neurodegenerative diseases
inflammasome
neuroinflammation
neurodegeneration
therapeutic targets
aging
Targeting cellular senescence via plasma-enhanced atomic layer deposition for anti-aging therapies
senescence
anti-aging
ALD coatings
biomedical engineering
regenerative medicine
Optimizing plasma membrane repair mechanisms to combat age-related cellular damage
plasma membrane repair
cellular aging
lipid bilayer
therapeutic interventions
membrane damage
For senolytic drug discovery: targeting mitochondrial dysfunction in aged mammalian cells
aging research
senotherapeutics
mitochondrial biology
drug discovery
cellular senescence
Targeting cellular senescence with senolytic drugs for age-related disease intervention
senolytics
aging biomarkers
age-related diseases
apoptosis resistance
inflammation
Targeting cellular senescence with few-shot hypernetworks for personalized age-related disease treatment
cellular senescence
hypernetworks
aging therapeutics
personalized medicine
few-shot learning
Investigating senolytic drug discovery using plasma membrane repair mechanisms in aging cells
senolytic drugs
plasma membrane repair
aging
cellular senescence
drug discovery
Decoding cellular aging mechanisms employing NAD+ boosting and single-cell transcriptomics
NAD+
aging
single-cell RNA-seq
senescence
metabolism
Developing senolytic drugs targeting mitochondrial dysfunction for age-related disease treatment
senolytics
mitochondrial dysfunction
aging
age-related diseases
drug discovery
For senolytic drug discovery during circadian rhythm minima
senolytics
circadian biology
aging therapeutics
drug timing
cellular senescence
Enhancing senolytic drug discovery with CRISPR-based senescence marker screening
senolytics
CRISPR
aging
drug discovery
biomarkers